As per Future Market Insights’ latest industry analysis, the valuation for the global clinical next-generation sequencing (NGS) data analysis industry size was around US$ 2.3 Billion in 2022, and the market is projected to exhibit growth at a CAGR of 17.4% over the forecast period, with an estimated valuation of around US$ 13.1 Billion by …